Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Barril

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|September 23, 2024
Use of the Novel Site-Directed Enzyme Enhancement Therapy (SEE-Tx) Drug Discovery Platform to Identify Pharmacological Chaperones for Glutaric Acidemia Type 1Madalena Barroso, Alexandra Puchwein-Schwepcke, Lars Buettner, et al.
International Journal of Molecular Sciences|May 4, 2026
Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio BNatàlia Pérez-Carmona, Elena Cubero, Ana Ruano, et al.
Angewandte Chemie (International Ed. in English)|November 21, 2025
Water Networks as Hydrophobic Recognition Motifs in ProteinsSerena G Piticchio, Miriam Martínez-Cartró, Salvatore Scaffidi, et al.
Journal of Medicinal Chemistry|June 25, 2005
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based designBrian W Dymock, Xavier Barril, Paul A Brough, et al.
Journal of Medicinal Chemistry|December 13, 2021
Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical SpaceSerena G Piticchio, Míriam Martínez-Cartró, Salvatore Scaffidi, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
4-Amino derivatives of the Hsp90 inhibitor CCT018159Xavier Barril, Mandy C Beswick, Adam Collier, et al.
Chemmedchem|November 11, 2015
Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth FactorNúria Bayó-Puxan, Ricard Rodríguez-Mias, Michael Goldflam, et al.
Plos One|November 29, 2023
Validation of a highly sensitive HaloTag-based assay to evaluate the potency of a novel class of allosteric β-Galactosidase correctorsMikhail Rudinskiy, Maria Pons-Vizcarra, Tatiana Soldà, et al.
Chemical Science|June 14, 2021
Fluorogenic Trp(redBODIPY) cyclopeptide targeting keratin 1 for imaging of aggressive carcinomasRamon Subiros-Funosas, Vivian Cheuk Lam Ho, Nicole D Barth, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 20, 2025
Discovering Uncharted Binding Pockets on E3 Ligases Leads to the Identification of FBW7 Allosteric ModulatorsMíriam Martínez-Cartró, Álvaro Serrano-Morrás, Andrea Bertran-Mostazo, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|September 23, 2024
Use of the Novel Site-Directed Enzyme Enhancement Therapy (SEE-Tx) Drug Discovery Platform to Identify Pharmacological Chaperones for Glutaric Acidemia Type 1Madalena Barroso, Alexandra Puchwein-Schwepcke, Lars Buettner, et al.
International Journal of Molecular Sciences|May 4, 2026
Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio BNatàlia Pérez-Carmona, Elena Cubero, Ana Ruano, et al.
Angewandte Chemie (International Ed. in English)|November 21, 2025
Water Networks as Hydrophobic Recognition Motifs in ProteinsSerena G Piticchio, Miriam Martínez-Cartró, Salvatore Scaffidi, et al.
Journal of Medicinal Chemistry|June 25, 2005
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based designBrian W Dymock, Xavier Barril, Paul A Brough, et al.
Journal of Medicinal Chemistry|December 13, 2021
Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical SpaceSerena G Piticchio, Míriam Martínez-Cartró, Salvatore Scaffidi, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
4-Amino derivatives of the Hsp90 inhibitor CCT018159Xavier Barril, Mandy C Beswick, Adam Collier, et al.
Chemmedchem|November 11, 2015
Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth FactorNúria Bayó-Puxan, Ricard Rodríguez-Mias, Michael Goldflam, et al.
Plos One|November 29, 2023
Validation of a highly sensitive HaloTag-based assay to evaluate the potency of a novel class of allosteric β-Galactosidase correctorsMikhail Rudinskiy, Maria Pons-Vizcarra, Tatiana Soldà, et al.
Chemical Science|June 14, 2021
Fluorogenic Trp(redBODIPY) cyclopeptide targeting keratin 1 for imaging of aggressive carcinomasRamon Subiros-Funosas, Vivian Cheuk Lam Ho, Nicole D Barth, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 20, 2025
Discovering Uncharted Binding Pockets on E3 Ligases Leads to the Identification of FBW7 Allosteric ModulatorsMíriam Martínez-Cartró, Álvaro Serrano-Morrás, Andrea Bertran-Mostazo, et al.
Pageof 9